CHAPTER 6: Microalgae as an Alternative Sustainable Source of Squalene
Published:10 May 2021
T. S. Chandra, C. K. M. Balaji, and P. R. Babu, in Microalgal Biotechnology: Recent Advances, Market Potential, and Sustainability, ed. A. Shekh, P. Schenk, and R. Sarada, The Royal Society of Chemistry, 2021, pp. 169-189.
Download citation file:
Squalene is a high value, C30-terpenoid and forms an intermediary metabolite of sterol synthesis in plants. It finds broad applications in the pharma-nutra and cosmeceutical industries with a market value of 212 million USD. Squalene is widely used as an antioxidant and as an adjuvant in vaccines. Currently over 50% of global squalene comes from the mass killing of deep-sea sharks (around 6 million) to meet annual demand with the remainder coming from plant oil sources that are erratic in terms of reliable production. Microalgae, photoautotrophic organisms which are the source of various value-added products, could be a potential candidate as an alternative to shark-based squalene. The present chapter discusses the ability of microalgae to produce squalene, its biosynthesis and possible microalgae-based biorefinery strategies for the sustainable production of squalene.